| Title | Therapeutic targets of rosuvastatin on heart failure and associated biological mechanisms: A study of network pharmacology and experimental validation |
| Authors | Lian, Zheng Song, Jun-Xian Yu, Shi-Ran Su, Li-Na Cui, Yu-Xia Li, Su-Fang Lee, Chong-Yoo Liang, Hui-Zhu Chen, Hong |
| Affiliation | Peking Univ, Dept Cardiol, Peoples Hosp, Beijing, Peoples R China Peking Univ, Beijing Key Lab Early Predict & Intervent Acute M, Peoples Hosp, Beijing, Peoples R China Peking Univ, Ctr Cardiovasc Translat Res, Peoples Hosp, Beijing, Peoples R China |
| Issue Date | 15-Mar-2021 |
| Publisher | EUROPEAN JOURNAL OF PHARMACOLOGY |
| Abstract | To explore the potential targets underlying the effect of rosuvastatin on heart failure (HF) by utilizing a network pharmacology approach and experiments to identify the results. PharmMapper and other databases were mined for information relevant to the prediction of rosuvastatin targets and HF-related targets. Then, the rosuvastatinHF target gene networks were created in Cytoscape software. Eventually, the targets and enriched pathways were examined by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. Furthermore, we constructed an HF animal model and used rosuvastatin to treat them, identifying the changes in heart function and related protein expression. We further used different cells to explore the mechanisms of rosuvastatin. Thirty-five intersection targets indicated the therapeutic targets linked to HF. GO analysis showed that 481 biological processes, 4 cellular components and 23 molecular functions were identified. KEGG analysis showed 13 significant treatment pathways. In animal experiments, rosuvastatin significantly improved the cardiac function of post-myocardial infarction mice and prevented the development of HF after myocardial infarction by inhibiting IL-1B expression. Cell experiments showed that rosuvastatin could reduce the expression of IL-1B in HUVEC and THP-1 cells. The therapeutic mechanism of rosuvastatin against HF may be closely related to the inhibition of the expression of apoptosis-related proteins, inflammatory factors, and fibrosis-related genes. However, IL-1B is one of the most important target genes. |
| URI | http://hdl.handle.net/20.500.11897/604988 |
| ISSN | 0014-2999 |
| DOI | 10.1016/j.ejphar.2021.173888 |
| Indexed | SCI(E) |
| Appears in Collections: | 人民医院 |
